Related Experiment Video
Updated: Aug 14, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Cytoplasmic suppression of tumorigenicity in reconstructed mouse cells
1Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas 75235.
Abstract:
Previous cybrid studies aimed at demonstrating cytoplasmic suppression of tumorigenicity have been generally inconclusive because of (a) the use of mutagens or carcinogens to introduce nuclear-coded and cytoplasmic-coded genetic markers and (b) dilution of putative cytoplasmic suppressors with tumorigenic cytoplasm of whole cells used in the cybrid construction. We have circumvented these potential problems by examining tumorigenicity in reconstructed cells made from tumorigenic karyoplasts and nontumorigenic cytoplasts and by using a ricin-antiricin selection to obtain the reconstructed cells. Karyoplasts from tumorigenic NIH/3T3 cells that were derived from a clone that had survived incubation with benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxy (anti) and been passaged 17 times were fused to NIH/3T3 cytoplasts derived from nontumorigenic cells. The cytoplasts were loaded with antiricin antibody prior to fusion. Ten clones which survived ricin selection were not tumorigenic in nude mice. These findings offer support for the presence of cytoplasmic factors in nontumorigenic mouse cells that suppress benzo(a)pyrene epoxide-induced tumorigenicity.
Insights
Nontumorigenic cytoplasm suppressed cancer development in reconstructed cells. This study identified cytoplasmic factors that inhibit tumor formation, offering new insights into cancer suppression mechanisms.
Area of Science:
- Cell Biology
- Cancer Research
- Genetics
Background:
- Cytoplasmic suppression of tumorigenicity studies have yielded inconclusive results.
- Previous methods used mutagens and cell dilution, complicating findings.
Purpose of the Study:
- To investigate the role of cytoplasmic factors in suppressing tumorigenicity.
- To overcome limitations of previous cybrid studies.
Main Methods:
- Constructed cells using tumorigenic karyoplasts and nontumorigenic cytoplasts.
- Employed ricin-antiricin selection for cell isolation.
- Utilized NIH/3T3 cells and benzo(a)pyrene epoxide treatment.
Main Results:
- Ten selected clones exhibited no tumorigenicity in nude mice.
- Demonstrated successful suppression of induced tumorigenicity.
Conclusions:
- Nontumorigenic mouse cell cytoplasm contains factors suppressing benzo(a)pyrene epoxide-induced tumorigenicity.
- Findings support the presence of cytoplasmic suppressors of cancer development.
Related Concept Videos
In-vitro Mutagenesis
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

